Hair Loss with Levetiracetam in Five Patients with Epilepsy

    November 2013 in “ Seizure: European Journal of Epilepsy ”
    Xinyu Zou, Hong Zhao, Dong Zhou
    Studysummary This study reports that hair loss may be a rare side effect of levetiracetam in epilepsy patients and appears reversible upon dose reduction or cessation.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on seizure-journal.com →
    Discuss this study in the Community →

    Research cited in this study 8

    1. Can Zinc Depletion Play a Role in Levetiracetam-Induced Hair Loss? Considerations from a Case Study Epilepsy & Behavior · 2013
    2. Serum Drug Level-Related Sodium Valproate-Induced Hair Loss Indian Journal of Pharmacology · 2013
    3. The Influence of Valproic Acid and Carbamazepine Treatment on Serum Biotin and Zinc Levels and on Biotinidase Activity Journal of child neurology · 2011
    4. Alopecia in Association with Lamotrigine Use Drug safety · 2010
    5. The Influence of Valproic Acid Treatment on Hair and Serum Zinc Levels and Serum Biotinidase Activity European journal of paediatric neurology · 2008
    6. Telogen Effluvium Caused by Magnesium Valproate and Lamotrigine Acta dermato-venereologica · 2004
    7. Alopecia with Carbamazepine in Two Patients with Focal Seizures Journal of neurology, neurosurgery and psychiatry · 1997
    8. Drug-Induced Hair Loss and Hair Growth Drug Safety · 1994

    Related research 1

    1. Hair Loss with Levetiracetam in Five Patients with Epilepsy Seizure: European Journal of Epilepsy · 2013